Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

Subunit vaccine of porcine pseudorabies virus and preparation method

Process for preparing an attenuated tetravalent dengue vaccine

PSEUDOMONAS ANTIGENS AND ANTIGEN COMBINATIONS

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

Process for preparing pneumococcal polysaccharide-protein conjugates

VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

Methods of treating and preventing influenza infections

Inactivated canine influenza vaccines and methods of making and uses thereof

Bird flu vaccine combination comprising virus-like particles and novel adjuvants

Antigens and vaccines directed against human enteroviruses

Injectable vaccines against multiple meningococcal serogroups

Methods and compositions for immune protection against extra-intestinal pathogenic

VACCINE FOR INTRAUTERINE DISEASE

Tetanus toxoid and CCL3 improve DC vaccines

Influenza vaccines

Methods and compositions for therapeutic agents

Live recombinant measles-M2 virus—its use in eliciting immunity against influenza viruses

COMPOSITIONS, METHODS OF ADMINISTRATION AND USES FOR TRIVALENT DENGUE VIRUS FORMULATIONS

deletion mutants, non-yeast vectors encoding deletion mutants, and their use

Fusion proteins and combination vaccines comprising haemophilus influenzae Protein E and Pilin A

Epitope focusing by variable effective antigen surface concentration

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

fusion protein and construction method and use thereof

Meningococcus vaccines

Pneumococcal capsular saccharide conjugate vaccine

Human herpesvirus immunotherapy

ADJUVANTED INFLUENZA VACCINES FOR PEDIATRIC USE

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Broad spectrum conjugate vaccine to prevent klebsiella pneumoniae and pseudomonas aeruginosa infections

Concomitant dengue and yellow fever vaccination

IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS

Methods and compositions for combination immunotherapy

Pepmixes to generate multiviral CTLs with broad specificity

VACCINES FOR THE TREATMENT AND PREVENTION OF IGE MEDIATED DISEASES

Peptide sequences and compositions

Parenteral norovirus vaccine formulations

Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides

Chimeric proteins

Compositions and methods for the treatment or prevention of human immunodeficiency virus infection

Antigenically matched influenza vaccines

Methods of use of influenza vaccine for prevention of pneumonia

Soft gel delivery method for treating poultry

Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

Multivalent enterovirus vaccine compositions and uses related thereto

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

Combination vaccines with lower doses of antigen and/or adjuvant

Method for inducing early T memory response with short peptides anti-tumor vaccine

Recombinant proteins and their therapeutic uses

Vaccine composition and preparation method and use thereof

Multivalent meningococcal polysaccharide-protein conjugate vaccine

Non-gelatin vaccine protectant composition and live attenuated influenza vaccine

Shared neoantigens

Surface display of antigens on gram-negative outer membrane vesicles

Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof

Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof

Peptide sequences and compositions

Attenuated swine influenza vaccines and methods of making and use thereof

Nanoparticles for use as a therapeutic vaccine

Virus-like particles

Vaccine combination against multiple dengue virus serotypes and preparation and application thereof

Compositions, methods and therapies for administering antigen peptide

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions

Compositions comprising proteins

Immunogenic compositions and uses thereof

Immunogenic composition comprising mycoplasma antigens

CDCA1 epitope peptides for Th1 cells and vaccines containing the same

Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same

ExPEC glycoconjugate vaccine formulations

Functional influenza virus like particles (VLPs)

Immune modulator for immunotherapy and vaccine formulation

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

Immunogenic composition

IMMUNOGENIC COMPOSITION FOR USE IN THERAPY

Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Anti-vaccine using sendai virus as vector

Swine influenza vaccine

EHV insertion site ORF70

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease

Immunogenic polypeptides

Immunogenic influenza composition

Immunogenic composition

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

Polypeptides and immunizing compositions containing polypeptides and methods of use

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

DOSE SELECTION OF ADJUVANTED SYNTHETIC NANOCARRIERS

COMPOSITION AND USES THEREOF

compositions and methods thereof

H3 influenza A virus

Combination purified inactivated vaccine for flaviviruses

Liposomal adjuvant compositions

Peptide mixture

Multivalent nanoparticle-based vaccines

Attenuated vaccines and methods of making and use thereof

POLYMER PARTICLES AND USES THEREOF

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

Nucleic acids for treatment of allergies

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

COMPOSITIONS AND METHODS FOR RAPID IMMUNIZATION AGAINST DENGUE VIRUS

compositions and methods thereof

Immunogenic compositions for use in pneumococcal vaccines

Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers

Synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza

METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY

Dengue virus vaccine compositions and methods of use thereof

Adjuvanting meningococcal factor H binding protein

Compositions and methods for treatment of cytomegalovirus

Influenza H5 vaccines

METHOD FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Infectious pancreatic necrosis virus (IPNV) vaccine compositions

proteins and nucleic acids

Subunit immersion vaccines for fish

Combination PIV3/hMPV RNA vaccines

Process for ready-to-use PCV/M.Hyo combination vaccine

Polysaccharide and uses thereof

MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer

Pertussis vaccines and methods of making and using

Method for Producing and Vaccine Composition of Neisseria Meningitidis Serogroups A, C, Y, and W-135 Oligosaccharides Conjugated to Glycan-Free Carrier Protein

Multivalent stable vaccine composition and methods of making same

Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications

Peptide mixture

HIV vaccines comprising one or more population episensus antigens

Temperature sensitive multivalent vaccines

Therapeutic multi-peptides T specific immune therapy for treatment of brain metastasis

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

Sequence arrangements and sequences for neoepitope presentation

Compositions comprising CH848 envelopes and uses thereof

HVT-vectored ND-IBD vaccine

Attenuated strains

CAPSULE FOR THE ORAL ADMINISTRATION OF BIOPHARMACEUTICALS

Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines

vaccine combination

Xenogenic normal tissue-derived vaccines for breaking the immune tolerance to tumor-associated, antigens

Pichinde virus reverse genetics systems and methods of use

Compositions and methods for dengue virus chimeric constructs in vaccines

LPS vaccine

OmpA in vaccine compositions and as diagnostic targets

Multigenome retroviral vector preparations and methods and systems for producing and using same

Combined enteropathogen recombinant construct

METHODS OF IDENTIFYING ANTIGENS FOR VACCINES

Broad spectrum conjugate vaccine to prevent and infections

Emulsified vaccine to obtain formulations of concentrated IgY immunoglobulins; processes and uses for the same

DNA-peptide combination vaccine

Compositions and methods to treat aids

Optimized HIV envelope gene and expression thereof

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

Dual purpose universal influenza vaccine confers protective immunity against anthrax

Inactivated equine influenza virus vaccines

Functional influenza virus-like particles (VLPS)

Three-component-multistage malaria vaccine

Oil-in-water emulsion influenza vaccine

Attenuated vaccines and methods of making and use

Multivalent vaccine for protection against mycobacterial infections and methods of using the same

Peptidic chimeric antigen receptor T cell switches and uses thereof

Anti-CD40 antibodies and methods of treating cancer having CD40+ tumor cells

Tetravalent dengue vaccine

Polyvalent pneumococcal polysaccharide-protein conjugate composition

Vaccine in the form of a recombinant sero type 9 avian adenovirus vector

Functional influenza virus-like particles (VLPs)

Antigen for use in malaria

Vaccine pharmaceutical composition for transdermal administration

Vaccine for PCV2 and mycoplasma

PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine

Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof

IMMUNOGENIC LHRH COMPOSITION AND USE THEREOF IN PIGS

Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria

IMMUNOGENIC COMPOSITION

Mycoplasma hyopneumoniae vaccine

Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus

Cancer vaccines

Glycoconjugate vaccines

KIF20A epitope peptides for TH1 cells and vaccines containing the same

Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins

Peptide mixture

Vaccination with mRNA-coded antigens

Composite antigenic sequences and vaccines

M Hyo Multivalent Vaccine and Uses Thereof

In situ antigen-generating cancer vaccine

Thermostable spray dried rotavirus vaccine formulation and process thereof

Live attenuated chimeric porcine circovirus vaccine

Hybrid core feline vaccines

Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

COMBINATION NEISSERIAL COMPOSITIONS

AIPA, OMPA, and ASP14 in vaccine compositions and diagnostic targets for anaplasma phagocytophilum infection

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

Dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection

Compositions and methods of enhancing immunogenicity of polysaccharide protein conjugates

HPV vaccine formulations comprising aluminum adjuvant and methods of producing same

Vaccine against porcine circo virus type 2

Immunological compositions containing attenuated

Recombinant swine influenza virus and uses thereof

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

Multivalent glycoconjugate vaccines

Mutant staphylococcal antigens

strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis

Methods for inducing an immune response

Polyvalent influenza virus-like particles (VLPS) and use as vaccines

Capsular gram-positive bacteria bioconjugate vaccines

Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

Soluble needle arrays for delivery of influenza vaccines

Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine development

Vaccine composition and uses thereof

Chimeric West Nile/Dengue viruses and methods of use

Mixed allergen compositions and methods for using the same

Mixed allergen compositions and methods for using the same

Mixed allergen compositions and methods for using the same

Gene optimized hantaan virus M segment DNA vaccine for hemorrhagic fever with renal syndrome

Methods for inducing an immune response

MOSAIC HIV-1 SEQUENCES AND USES THEREOF

H3 influenza A virus

Multi-component-multistage malaria vaccines

Uses of parasite macrophage migration inhibitory factors

Soft gel delivery system for treating poultry

Methods and compositions for live attenuated viruses

Vaccine for intrauterine disease

Methods and compositions for chimeric coronavirus spike proteins

Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof

Hendra virus recombinant compositions and uses thereof

Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains

IMMUNOGENIC COMPOSITIONS AND EXPRESSION SYSTEMS

ALLERGEN FOR PROPHYLACTIC TREATMENT OF ALLERGY

Swarm immunization with envelopes from CH505

Combinatorial platform for the display of surface adjuvants and antigens

Methods and materials for treating cancer

Methods and materials for treating cancer

Multivalent VLP conjugates

Vaccine compositions comprising a saponin adjuvant

Immunogenic composition

Process for preparing an attenuated tetravalent dengue vaccine

Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Mixed allergen compositions and methods for using the same

Virus like vesicles (VLVS) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection

Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector

West Nile Virus vaccine

Compositions, methods and uses for dengue virus serotype-4 constructs

Vaccines based on hepatitis B core antigens

Prophylactic vaccine against egg drop syndrome (EDS)

Method for reducing HIV-1 reservoir size using multivalent immunogen and reservoir purging agent

M.tuberculosis vaccines

Chimeric viruses presenting non-native surface proteins and uses thereof

Composition comprising branched multipeptide vaccine and vaccine comprising the same

Immune enhancing recombinant dengue protein

Fusion proteins and combination vaccines comprising protein E and pilin A

Peptide sequences and compositions

Immunogens and methods for discovery and screening thereof

HLA-A2 tumor associated antigen peptides and compositions

Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases

Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof

Vaccine compositions

Method for the preparation of a vaccinating agent

Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance

Modified meningococcal fHbp polypeptides

UspA2 protein constructs and uses thereof

Multivalent stable vaccine composition and methods of making same

Compositions and methods for the treatment or prevention of hepatitis B virus infection

Constrained immunogenic compositions and uses therefor

COMPOSITION FOR TREATING PROSTATE CANCER (PCa)

COMBINATION THERAPY FOR IMMUNOSTIMULATION

Alphavirus replicon particles matched to protein antigens as immunological adjuvants

Dengue virus E-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes

Multivalent pneumococcal polysaccharide-protein conjugate composition

Immunogenic compositions and methods

Avirulent, immunogenic flavivirus chimeras

Immunogenic compositions comprising

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell

H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT

Influenza virus vaccines and uses thereof

Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy

Injectable vaccines against multiple meningococcal serogroups

Poultry virus vaccines that are liquid stable

Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases

Sin Nombre virus full-length M segment-based DNA vaccines

Type III secretion injectisome proteins for treatment and prevention of chlamydial infections

Attenuated live vaccine against mycoplasmal pneumonia of swine (MPS) and use thereof

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxin

Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors

Combination therapy with neoantigen vaccine

Mutant fragments of OspA and methods and uses relating thereto

Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy

Vaccines against HPV and HPV-related diseases

Multivalent meningococcal conjugates and methods for preparing conjugates

Peptide mixture

Aluminum compounds for use in therapeutics and vaccines

Peptide particle formulation

Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof

Streptococcus pneumoniae capsular polysaccharides and conjugates thereof

capsular polysaccharides and conjugates thereof

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

Multivalent breast cancer vaccine

Programming of cells for tolerogenic therapies

DCLK1 short form specific binding agents

Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines

Multi-epitope TARP peptide vaccine and uses thereof